Travere Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $50M | 5.5M | 8.99 |
| 2023-09-30 | $42M | 4.7M | 8.94 |
| 2023-06-30 | $65M | 4.2M | 15.36 |
| 2023-03-31 | $90M | 4.0M | 22.49 |
| 2022-12-31 | $74M | 3.5M | 21.03 |
| 2022-06-30 | $81M | 3.3M | 24.23 |
| 2022-03-31 | $99M | 3.8M | 25.77 |
| 2021-09-30 | $94M | 3.9M | 24.25 |
| 2021-06-30 | $56M | 3.8M | 14.59 |
| 2021-03-31 | $100M | 4.0M | 24.97 |
| 2020-12-31 | $93M | 3.4M | 27.25 |